IRIS Emerging Themes

To complement the Education Topics articles, the IRIS Board has decided to commission occasional articles and provide statements on subjects currently discussed in veterinary medicine but whose future significance is still being investigated. The latest statement concerns active kidney injury biomarkers and their use in diagnosis and monitoring of kidney disease.

NEW: Active Kidney Injury Biomarkers in the Diagnosis of Kidney Diseases

The IRIS Board June 2023

Renal Fibrosis in Cats

Scott Brown, Athens, Georgia, USA

FGF-23: a new player in the regulation of phosphate

J Elliott, London, UK

Stem Cell Therapy for CKD: What do we know? (2018)

Jessica M. Quimby, Columbus, Ohio, USA

Symmetric dimethylarginine (SDMA): a new biomarker of renal function in cats and dogs

SA Brown, Athens, USA